Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HAO | Ann:Appendix 3A and Half Yearly Report (Price Sensitive) | 14/03/24 | 0 | 97 | |||
|
|||||||
HAO | Ann:Change of Share Registry - Effective from Monday, 4th of March, 2024 (Price Sensitive) | 11:15 | 0 | 86 | |||
|
|||||||
HAO | Ann:Quarterly Update (Price Sensitive) | 31/01/24 | 0 | 116 | |||
|
|||||||
HAO | Ann:Quarterly Cashflow Report (Price Sensitive) | 31/01/24 | 0 | 139 | |||
|
|||||||
HAO | Ann:Strategic Partnership with SCPICI (Price Sensitive) | 31/01/24 | 0 | 139 | |||
|
|||||||
HAO | Ann:Application for Quotation of Additional Securities | 08/12/23 | 0 | 217 | |||
|
|||||||
HAO | Ann:Results of AGM | 30/11/23 | 0 | 193 | |||
|
|||||||
HAO | Ann:Quarterly Cashflow Report (Price Sensitive) | 31/10/23 | 0 | 239 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |